secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0000950170-23-013745
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics stockholders approve reverse stock split authorization at annual meeting
--------------------------------------------------------------------------------

- Reverse stock split approved; ratio of 1:3 to 1:15 to be set by board at a later date.
- All six director nominees elected, including Marc Hedrick and Howard Clowes.
- BDO USA ratified as independent auditor for 2023; say-on-pay passed with 4.58M for.
- Stockholders favored one-year frequency for future advisory votes on executive compensation.
- Amended 2020 Stock Incentive Plan approved; preferred stock (50M votes) voted proportionally on split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000095017023013745/0000950170-23-013745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000095017023013745/pstv-20230420.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-013745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer